ISRG Q3 deep dive: margin pressure overshadows strong adoption and international growth
Intuitive Surgical to Face Potential Risks in 2027 Procedure Momentum From Pricing Actions, RBC Says
Leerink Partners Maintains Outperform on Intuitive Surgical, Raises Price Target to $503
JP Morgan Maintains Overweight on Intuitive Surgical, Raises Price Target to $475
Evercore ISI Group Maintains In-Line on Intuitive Surgical, Lowers Price Target to $385
Loading...